Trial in Progress: A Phase 1 Study of KTX-1001, an Oral, First-in-Class, Selective MMSET Inhibitor in Patients with Relapsed and Refractory Multiple MyelomaJesus G. Berdeja,David Dingli,Sagar Lonial,Andrew J. Yee,Alfred Chung,Cristina Gasparetto,P. Leif Bergsagel,Vivek Roy,Al-Ola Abdallah,Sharmilan Thanendrarajan,Aimaz Afrough,Laura Rosinol,Suzanne Trudel, Paula Rodriguez Otero, Cyrille Touzeau,Pierre Bories, Soo Bang, Terry Connolly, Michelle Kim, Chad A. Lewis, Bao-Van Tran Linberg, M. Travis Quigley, Ola Landgren, Saad Z. Usmani, Maria-Victoria Mateos, David S. SiegelBLOOD（2023）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
